Demographics of IFN-I autoAbs-positive and autoAbs-negative individuals from the Danish and American cohorts
| . | Danish cohort: IFN-I autoAbs-positive individuals . | Danish cohort: IFN-I autoAbs-negative individuals . | American cohort: IFN-I autoAbs-positive individuals . | American cohort: IFN-I autoAbs-negative individuals . |
|---|---|---|---|---|
| Number of individuals | 3 | 315 | 2 | 290 |
| Mean age, years [range] | 49.9 [29–67] | 46.6 [18–79] | 42.0 [28–56] | 41.7 [20–76] |
| Sex | ||||
| Male | 1/3 (33%) | 231/315 (73%) | 2/2 (100%) | 257/290 (88%) |
| Female | 2/3 (66%) | 63/315 (20%) | 0/2 (0%) | 31/290 (11%) |
| Unknown | 0/3 (0%) | 21/315 (7%) | 0/2 (0%) | 2/290 (1%) |
| Median CD4+ count (cells/μl) [range] | 550 [310–830] | 670 [133–2,143] | 574.5 [408–741] | 469 [9–1,530] |
| ART-treated | 3/3 (100%) | 257/315 (82%) | 0/2 (0%) | 0/290 (0%) |
| ART-naive | 0/3 (%) | 58/315 (18%) | 2/2 (100%) | 290/290 (100%) |
| . | Danish cohort: IFN-I autoAbs-positive individuals . | Danish cohort: IFN-I autoAbs-negative individuals . | American cohort: IFN-I autoAbs-positive individuals . | American cohort: IFN-I autoAbs-negative individuals . |
|---|---|---|---|---|
| Number of individuals | 3 | 315 | 2 | 290 |
| Mean age, years [range] | 49.9 [29–67] | 46.6 [18–79] | 42.0 [28–56] | 41.7 [20–76] |
| Sex | ||||
| Male | 1/3 (33%) | 231/315 (73%) | 2/2 (100%) | 257/290 (88%) |
| Female | 2/3 (66%) | 63/315 (20%) | 0/2 (0%) | 31/290 (11%) |
| Unknown | 0/3 (0%) | 21/315 (7%) | 0/2 (0%) | 2/290 (1%) |
| Median CD4+ count (cells/μl) [range] | 550 [310–830] | 670 [133–2,143] | 574.5 [408–741] | 469 [9–1,530] |
| ART-treated | 3/3 (100%) | 257/315 (82%) | 0/2 (0%) | 0/290 (0%) |
| ART-naive | 0/3 (%) | 58/315 (18%) | 2/2 (100%) | 290/290 (100%) |